Use of aflibercept in the management of diabetic retinopathy

,

Lloyd Clark, MD, highlights his ASRS presentation focusing on the PANORAMA study detailing the use of aflibercept in the management of diabetic retinopathy.

Lloyd Clark, MD, of Palmetto Retina Center, previews his ASRS poster, which focuses on the PANORAMA Study, which reviews the use of aflibercept in the management of diabetic retinopathy. He will present his poster during a reception on July 15 at this year’s American Society of Retina Specialists meeting in New York.

Related Content:

ConferencesRetinaTherapeutics TherapeuticsClinical DiagnosisDME
Palatin reports positive interim analysis in Phase 3 pivotal study of potential therapeutic for patients with dry eye disease
Study: Eye doctors receiving even small payments from drug companies more likely to prescribe name-brand eyedrops
Bioengineered cornea can restore sight to the blind and visually impaired